The β1-adrenergic receptor (β1-AR) mRNAs are post-transcriptionally regulated at the level of mRNA stability and undergo accelerated agonist-mediated degradation. Treatment of cells with leptomycin B, an inhibitor of the nuclear export receptor CRM 1, results in a dramatic enhancement of β1-AR mRNA stability. To assess whether CRM 1 or other nuclear export receptors play direct roles in β1-AR mRNA down-regulation, we used cell-permeable peptides containing the leucine-rich nuclear export signal (NES) recognized by CRM 1, to serve as inhibitors of CRM 1-mediated nuclear export. When DDT1MF2 transfectants ectopically expressing β1-AR mRNAs were concurrently treated with isoproterenol and peptide inhibitors, only the co-addition of the NES inhibitor reversed the isoproterenol-induced reduction of β1-AR mRNA levels. Using UV-crosslinking/immunoprecipitation analyses, we have verified the interaction of CRM 1 – HuR complexes with the β1-AR mRNA. CRM 1 is nearly absent in neonatal rat cortical neurons (RCNs), which express abundant β1-AR mRNAs but do not undergo agonist-mediated β1-AR mRNA down-regulation. Upon transfection with a CRM 1 expression recombinant, the neonatal RCNs exhibit agonist-mediated β1-AR mRNA down-regulation and decreased β1-AR transcript stability. We conclude that agonist-mediated β1-AR mRNA down-regulation and degradation utilize the CRM 1-mediated nucleocytoplasmic export pathway for deposition of transcripts into the cytoplasm. Supported by NIH MH071317 and MH63137.